Required Fields *
Submit Close
Print

Let Our Family Care for Your Family!

Our Research

Advancing Therapies for Patients

Sarah Cannon Research Institute (SCRI) is a global strategic research organization focusing on advancing therapies and accelerating drug development. It is one of the largest clinical research programs, conducting community-based clinical trials in oncology, cardiology and other therapeutic areas through affiliations with a network of more than 700 physicians in the United States and United Kingdom. Additionally, SCRI offers management, regulatory and other research support services to drug development sponsors and strategic investigator sites. 

  • Our work-SCRI is a research institution that sponsors oncology clinical trials through its affiliation with clinical oncology practices throughout the country. This work makes it possible for thousands of patients to participate in research studies close to home.
  • Our services to physician investigators and industry—SCRI provides research support services to physicians and drug development sponsors across the country.